DAVA heads into its May 18 Q3 results with options traders making a speculative bet on a bounce — even as the stock trades near multi-year lows and every recent analyst move has been a cut.
The most notable development this week is in the options market. Positioning has turned conspicuously bullish, with the put/call ratio at 0.12 — near its 52-week low and well below its 20-day average of 0.14. A sweep of July $5 calls crossed on May 6, 1,429 contracts near the ask against just 430 in open interest, a signal that at least one participant is making a directional bet on recovery ahead of earnings. That optimism runs against a stock that has fallen 34% year-to-date to $4.16 and dropped another 8% in the past month alone.
Short interest is a secondary tension. At roughly 4% of the free float — up about 1.9% on the week but down 7% over the past month — the short base is present but not dominant. Cost to borrow has eased to 0.54%, down 12% on the week and 10% on the month, pointing to loose borrow conditions and no meaningful squeeze pressure in the lending pool. With days-to-cover at 11.5, unwinding would take time, but the borrow market itself is not stressed. The short score of 48.8 is mid-range and has drifted lower over the past two weeks, consistent with a position that is modestly rebuilding but nowhere near crowded.
The Street's problem with DAVA is structural, not just sentiment. Every analyst action in the past six months has been a price-target reduction. TD Cowen cut to $6.00 in early April while maintaining Buy — the most recent move and a bellwether read given its proximity to earnings. JP Morgan holds Neutral at $9.00, Needham keeps Buy at $7.00, and the mean target across the coverage sits at $6.33, implying over 50% upside from current levels. The gap between the analyst consensus and the stock price reflects deep scepticism that estimates are anchored to reality. The valuation multiples underline how far the de-rating has gone: the trailing PE has compressed to 3.5x over the past 30 days and EV/EBITDA sits at just 3.4x — levels that typically only appear when the market is pricing in sustained earnings deterioration or outright distress. Bulls argue the AI-native delivery transition creates medium-term optionality at a deep discount; bears counter that the pivot is compressing margins and IT spending headwinds are not yet clearing.
Institutional ownership offers some grounding. T. Rowe Price added nearly 192,000 shares in Q1 to reach a 7.7% stake. Paradice Investment Management added over 1.1 million shares through year-end 2025, building to 5.7% of the register. Both moves represent conviction at prices well above current levels, and neither has been publicly unwound. The insider picture is quieter — a handful of directors received awards and immediately sold token amounts in late March and early April, all below $2,500 in value and of minimal significance.
The earnings history is unhelpful for bulls. The last two confirmed prints each produced a first-day decline of around 5%, with losses widening to roughly 6% by the end of the following week. The May 18 release arrives with the stock already under sustained pressure, which could mean less room to fall — or simply that the bar for a relief rally is higher than it appears.
The key question heading into May 18 is whether management can signal that the AI-delivery transition is generating revenue momentum rather than just cost pressure — because at 3.5x earnings and with calls accumulating, the market is priced for a catalyst, not a delay.
See the live data behind this article on ORTEX.
Open DAVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
